PEP-Therapy

PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology. PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology We are thrilled to announce that PEP-Therapy has been selected as a laureate of the Paris Saclay Cancer Cluster (PSCC) BOOST grant to support the development of its Intracellular Drug Delivery Technology (IDDT).